Business
- Business
-
-
Less US urgency at G-8 in call for European growth
When leaders of the nation’s biggest economies gathered at the presidential retreat of Camp David last year, European elections had rattled the continent with a rejection of austerity measures.
-
US stocks edge lower at end of a volatile week
Stocks edged lower in the early going on Wall Street Friday as trading quieted down at the end of a turbulent week.
-
State sets meeting for scale service companies
Department of Agriculture officials are asking all licensed scale service companies to attend a meeting to discuss the low accuracy rate of heavy-capacity scales.
-
Court ruling may open up breast cancer gene tests
A ruling by the Supreme Court that human genes can’t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.
-
Cooper CEO says buyer committed to US operations
A tire maker whose main market is in India is buying Ohio’s Cooper Tire & Rubber Co. for $2.2 billion and making a commitment to maintain the company’s three U.S. manufacturing plants and retain its management operation in Ohio, Cooper’s chief executive said Wednesday.
-
Governor to lead Kansas delegation to Paris air show
Gov. Sam Brownback plans to lead a Kansas delegation to an international air show in Paris next week to promote the state’s aircraft industry.
-
Gannett to buy TV station owner Belo for $1.5B
Gannett said it reached a deal to buy TV station owner Belo for about $1.5 billion in cash, significantly boosting its presence in broadcasting.
-
US stock market moves sharply higher
Good news about hiring and retail sales helped send the U.S. stock market sharply higher Thursday.
-
1 dead, dozens hurt in Louisiana plant explosion
An ground-rattling explosion at a chemical plant in Louisiana ignited a blaze Thursday that killed at least one person and left dozens more hurt, officials said.
-
Court says human genes cannot be patented
The Supreme Court ruled Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries.
- More Business Headlines
-
Less US urgency at G-8 in call for European growth



